0001209191-17-013314.txt : 20170222 0001209191-17-013314.hdr.sgml : 20170222 20170222164840 ACCESSION NUMBER: 0001209191-17-013314 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170221 FILED AS OF DATE: 20170222 DATE AS OF CHANGE: 20170222 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NANOPHASE TECHNOLOGIES Corp CENTRAL INDEX KEY: 0000883107 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS PRIMARY METAL PRODUCTS [3390] IRS NUMBER: 363687863 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1319 MARQUETTE DRIVE CITY: ROMEOVILLE STATE: IL ZIP: 60446 BUSINESS PHONE: 6303231200 MAIL ADDRESS: STREET 1: 1319 MARQUETTE DRIVE CITY: ROMEOVILLE STATE: IL ZIP: 60446 FORMER COMPANY: FORMER CONFORMED NAME: NANOPHASE TECHNOLOGIES CORPORATION DATE OF NAME CHANGE: 19970305 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HENDERSON JAMES A CENTRAL INDEX KEY: 0001182603 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22333 FILM NUMBER: 17629090 MAIL ADDRESS: STREET 1: 301 WASHINGTON ST CITY: COLUMBUS STATE: IN ZIP: 47201 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-02-21 0 0000883107 NANOPHASE TECHNOLOGIES Corp NANX 0001182603 HENDERSON JAMES A 1319 MARQUETTE DRIVE ROMEOVILLE IL 60446 1 0 0 0 Common Stock 482115 D Stock Option (right to buy) 1.36 2012-01-31 2021-01-31 Common Stock 10000 10000 D Deferred Common Stock Common Stock 20030 20030 D Stock Option (right to buy) 0.52 2015-02-13 2024-02-13 Common Stock 10000 5000 D Common Stock (right to buy) 0.44 2016-02-18 2025-02-18 Common Stock 4500 9000 D Common Stock (right to buy) 0.42 2017-02-23 2026-02-23 Common Stock 12150 12150 D Common Stock (right to buy) 0.90 2016-11-17 2026-11-17 Common Stock 2000 2000 D Common Stock (right to buy) 1.05 2016-11-17 2026-11-17 Common Stock 2000 2000 D Common Stock (right to buy) 1.18 2016-11-17 2026-11-17 Common Stock 2000 2000 D Common Stock (right to buy) 0.84 2016-11-17 2026-11-17 Common Stock 2000 2000 D Common Stock (right to buy) 1.85 2016-11-17 2026-11-17 Common Stock 2000 2000 D Common Stock (right to buy) 1.10 2016-11-17 2026-11-17 Common Stock 2000 2000 D Common Stock (right to buy) 0.99 2016-11-17 2026-11-17 Common Stock 2000 2000 D Common Stock (right to buy) 0.68 2017-02-21 4 A 0 15000 0.68 A 2018-02-21 2027-02-21 Common Stock 15000 15000 D Subject to certain restrictions, beginning on this date, options vest in three equal annual installments. Each share of deferred common stock represents a right to receive one share of common stock. The deferred common stock becomes payable upon the reporting person's termination of service as a director of the Company. Pursuant to such plan, the reporting person elected to defer receipt of such shares and receive a cumulative total of 20,030 shares of deferred common stock which will all be accounted for under the Company's Non-Employee Director Deferred Compensation Plan. The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued at identical exercise prices to the conversion prices of the respective stock appreciation rights. 2,000 were issued with an exercise price of $0.90, 2,000 were issued with an exercise price of $1.05, 2,000 were issued with an exercise price of $1.18, 2,000 were issued with an exercise price of $0.84, 2,000 were issued with an exercise price of $1.85, 2,000 were issued with an exercise price of $1.10, and 2,000 were issued with an exercise price of $0.99. By Jess Jankowski under UPA for James A. Henderson 2017-02-22